23
Safety of irreversible electroporation treatment for metastatic disease in humans Silk Mikhail ; Wimmer, Thomas; Getrajdman, George; Durack, Jeremy; Sofocleous, Constantinos T.; Solomon, Stephen B. Interventional Radiology & Image Guided Therapies Memorial Sloan Kettering Cancer Center. New York, NY Email:[email protected]

Safety of irreversible electroporation treatment for metastatic disease in humans

  • Upload
    chaz

  • View
    33

  • Download
    0

Embed Size (px)

DESCRIPTION

Safety of irreversible electroporation treatment for metastatic disease in humans. Silk Mikhail ; Wimmer, Thomas; Getrajdman, George; Durack, Jeremy; Sofocleous, Constantinos T.; Solomon, Stephen B. Interventional Radiology & Image Guided Therapies - PowerPoint PPT Presentation

Citation preview

Page 1: Safety of irreversible electroporation treatment  for metastatic disease in humans

Safety of irreversible electroporation treatment for metastatic disease in humans

Silk Mikhail; Wimmer, Thomas; Getrajdman, George; Durack, Jeremy; Sofocleous, Constantinos T.; Solomon, Stephen B.

Interventional Radiology & Image Guided TherapiesMemorial Sloan Kettering Cancer Center. New York, NY

Email:[email protected]

Page 2: Safety of irreversible electroporation treatment  for metastatic disease in humans

Agenda Agenda

• Background on Ablation Devices

• Physics (RFA, MWA, IRE)

• Pre-Clinical Data

• Clinical Applications

Page 3: Safety of irreversible electroporation treatment  for metastatic disease in humans

  

300GHZ

3HZ

Thermal ablation uses Electromagnetic Spectrum

300 MHz

RFA

MWA

Thermal ablation uses the EM frequencies of 3 Hz and 300 GHz.

Page 4: Safety of irreversible electroporation treatment  for metastatic disease in humans

Irreversible ElectroporationIrreversible Electroporation

• Electroporation– Electric pulses create

tiny holes in the cell – Temporary as long as

the energy is low• 360 V/cm

– Chemotherapy and Genetic therapy delivery

• “Irreversible”– Higher energy

• 680 V/cm1

• Create permanent holes in the cell

• Cell loses essential molecules and internal signals tell the cell to die

Page 5: Safety of irreversible electroporation treatment  for metastatic disease in humans

ElectroporationElectroporation

• Reversible electroporation is used to allow genes and drugs to enter cells (300-600 V/cm)

• Direct current pulse leads to elevation of transmembrane potentials creating permanent cell membrane pores: ~1,500 V/cm

• Strong electric fields applied across a cell can cause:

Irreversible permeabilizationof the cell membrane: “IRE”

Page 6: Safety of irreversible electroporation treatment  for metastatic disease in humans

How IRE kills cellsHow IRE kills cells

Page 7: Safety of irreversible electroporation treatment  for metastatic disease in humans

Advantages of IREAdvantages of IRE

• IRE is non-thermal

– Little to no scar tissue formation– Structural Protein Sparing

• Nerves and bile ducts in the area of ablation have the potential to heal after treatment

– No heat sink effect• Compared to thermal techniques where blood flow dissipates

heat. Electric pulses are not effected by blow flow.

Page 8: Safety of irreversible electroporation treatment  for metastatic disease in humans

Patient DemographicsPatient Demographics

Table 1. Patient Demographics

Variable Data

Total number of patients included 29

Age range: 42y-81y

Sex:

Male 16

Female 13

Treated tumor lesions 43

Table 2. Tumor characteristics

Variable Data

Total Tumors 43

Tumor Size 2.3cm

<1 cm 6

1-2 cm 13

2.1-3 cm 12

>3 cm 12

Tumor location

Liver 29

Soft Tissue 12

Lung 1

Tumor type (%)

Metastatic Colorectal 26

Metastatic Pancreatic 6

Metastatic Endometrial 3

Metastatic Prostatic 3

Metastatic Leiomyosarcoma 2

Metastatic Hemangiopericytoma 1

Metastatic Ovarian 1

Metastatic Thyroid 1

Page 9: Safety of irreversible electroporation treatment  for metastatic disease in humans

Multiple IRE electrodes to treat larger Multiple IRE electrodes to treat larger lesions minimum: lesions minimum: 2 parallel electrodes spaced 1.5-2 cm2 parallel electrodes spaced 1.5-2 cm

Page 10: Safety of irreversible electroporation treatment  for metastatic disease in humans

NO Heat Sink Effect NO Heat Sink Effect

Page 11: Safety of irreversible electroporation treatment  for metastatic disease in humans

Case close to bile duct and major veinCase close to bile duct and major vein

• Pre-Tx • Tx • Post-Tx• 3 mo. f/u MRI

Page 12: Safety of irreversible electroporation treatment  for metastatic disease in humans

No tumor for +778 daysNo tumor for +778 days

Page 13: Safety of irreversible electroporation treatment  for metastatic disease in humans

Perivascular/periductal Liver MetastasesPerivascular/periductal Liver Metastases

28 patients/ 65 tumors: 1 arrhythmia; 1 PV thrombosis (3%) 6 months: 92% Complete Ablation

Kingham P et al: IRE for Perivascular Hepatic Malignant Tumors. J Am Coll Surg 2012; 215(3): 379-87

Page 14: Safety of irreversible electroporation treatment  for metastatic disease in humans

Applicators

Animal Lung IRE

Post IRE: GGO

1 week 3 weeks

LUNG close to bronchus

Page 15: Safety of irreversible electroporation treatment  for metastatic disease in humans

Tumor near airway Tumor near airway

• Pre-Tx • Tx • Post-Tx• 3 mo. PET scan

Page 16: Safety of irreversible electroporation treatment  for metastatic disease in humans

IRE as an Ablation Tool: Potential AdvantagesIRE as an Ablation Tool: Potential Advantages

• Non-Thermal:

-Application in Locations non eligible for Thermal Ablation

-Limit recurrences near vessels by avoiding the “heat sink”

effect

• Cellular Kill Mechanism Avoids Damage to:

- Extracellular Matrix. This may result in fewer complications:

Near Bile Ducts, Intestines, Ureters, Bronchi, Vital structures.

Page 17: Safety of irreversible electroporation treatment  for metastatic disease in humans

51 year old with rectal cancer recurrence near 51 year old with rectal cancer recurrence near rectumrectum

Page 18: Safety of irreversible electroporation treatment  for metastatic disease in humans

NO tumor for +565 days NO tumor for +565 days

Page 19: Safety of irreversible electroporation treatment  for metastatic disease in humans

Transmural Necrosis; No Perforation at 14 days

IRE Rectal Wall

Page 20: Safety of irreversible electroporation treatment  for metastatic disease in humans

Applications: IREWhere Thermal ablation is NOT feasible

• Pancreas: Locally advanced adenocarcinoma 100% success at 90 days. Martin RC e al J Am Coll Surg 2012; 215(3): 361-9

• Perivascular Liver Tumors. Kingham P et al: IRE for Perivascular Hepatic Malignant Tumors. J Am

Coll Surg 2012; 215(3): 379-87

• Prostate: A potential Therapeutic Paradigm Shift. Ward JF Curr Opin Urol

2012; (2): 104-108

• Intracranial: Canine brain Surgery. Garcia PA Conf Proc IEEE Eng Med Biol Soc 2009:

6513-6. and Technol Cancer Res Treat 2011; 10(1): 73-83

• Blood Brain barrier Disruption: Rat Hjoui M et al. MRI study on reversible and irreversible

electroporation induced blood brain barrier disruption. Plos One. 2012;7(8)

• Small Intenstine: Rat: Complete ablation but recovery of Epithelium in 3 weeks. Phillips MA. Br J Cancer 2012; 31; 106(3): 490-5

Page 21: Safety of irreversible electroporation treatment  for metastatic disease in humans

Enhancing Irreversible Electroporation

A zone of Reversible electroporation Surrounds the Area of IRE

A lethal agent can be targeted to the reversible zone:

ElectrochemotherapyGene Electrotransfer

Electrochemotherapy : A new technological approach in treatment of Liver Metastases. Edhemovic et al Technol Cancer Res Treat 2011 Oct; 10(5):475-85

Treatment Planning of Electroporation-Based medical Interventions: electrochemotherapy, gene electrotransfer and IRE Phys Med Biol 2012; 7;57(17)5425-40

Model assumes 360 V/cm threshold for reversible and 680 V/cm threshold for irreversible

Reversible

Irreversible

Page 22: Safety of irreversible electroporation treatment  for metastatic disease in humans

ConclusionConclusion

• Unlike Thermal Ablation, IRE, can be performed in close proximity to bile ducts, major vessels, bladder, rectum, and nerves, with an acceptable safety profile.

• Longer term follow up is performed to determine efficacy.

• Further research will determine the potential of this new ablation technology